Enterocin CRL 35
| Internal ID | 2ebcebb1-fba3-4199-8185-de4337f8a9be |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[(3R)-2-[[2-[[2-[[4-amino-2-[[2-[[2-[[2-(2,6-diaminohexanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]butanediamide |
| SMILES (Canonical) | CC(C)CC(C(=O)NC(CC(=O)N)C(=O)N)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCCCN)N |
| SMILES (Isomeric) | C[C@H](C(C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)N)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCCCN)N)O |
| InChI | InChI=1S/C51H78N14O15/c1-25(2)18-34(48(77)60-33(44(56)73)21-38(54)69)63-51(80)43(27(5)66)65-50(79)42(26(3)4)64-41(72)24-58-47(76)37(22-39(55)70)59-40(71)23-57-46(75)35(19-28-9-13-30(67)14-10-28)62-49(78)36(20-29-11-15-31(68)16-12-29)61-45(74)32(53)8-6-7-17-52/h9-16,25-27,32-37,42-43,66-68H,6-8,17-24,52-53H2,1-5H3,(H2,54,69)(H2,55,70)(H2,56,73)(H,57,75)(H,58,76)(H,59,71)(H,60,77)(H,61,74)(H,62,78)(H,63,80)(H,64,72)(H,65,79)/t27-,32?,33?,34?,35?,36?,37?,42?,43?/m1/s1 |
| InChI Key | WPOKJIHVXLKXHN-OHKMYPDRSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C51H78N14O15 |
| Molecular Weight | 1127.20 g/mol |
| Exact Mass | 1126.57710784 g/mol |
| Topological Polar Surface Area (TPSA) | 504.00 Ų |
| XlogP | -3.60 |
| Atomic LogP (AlogP) | -5.72 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 17 |
| Rotatable Bonds | 35 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8940 | 89.40% |
| Caco-2 | - | 0.8667 | 86.67% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.6714 | 67.14% |
| Subcellular localzation | Mitochondria | 0.6774 | 67.74% |
| OATP2B1 inhibitior | - | 0.8598 | 85.98% |
| OATP1B1 inhibitior | + | 0.8879 | 88.79% |
| OATP1B3 inhibitior | + | 0.9413 | 94.13% |
| MATE1 inhibitior | - | 0.9400 | 94.00% |
| OCT2 inhibitior | - | 0.8500 | 85.00% |
| BSEP inhibitior | + | 0.9666 | 96.66% |
| P-glycoprotein inhibitior | + | 0.7427 | 74.27% |
| P-glycoprotein substrate | + | 0.8697 | 86.97% |
| CYP3A4 substrate | + | 0.6784 | 67.84% |
| CYP2C9 substrate | - | 0.8036 | 80.36% |
| CYP2D6 substrate | - | 0.7419 | 74.19% |
| CYP3A4 inhibition | - | 0.7102 | 71.02% |
| CYP2C9 inhibition | - | 0.8937 | 89.37% |
| CYP2C19 inhibition | - | 0.7464 | 74.64% |
| CYP2D6 inhibition | - | 0.7958 | 79.58% |
| CYP1A2 inhibition | - | 0.9196 | 91.96% |
| CYP2C8 inhibition | + | 0.6129 | 61.29% |
| CYP inhibitory promiscuity | - | 0.9383 | 93.83% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6674 | 66.74% |
| Eye corrosion | - | 0.9895 | 98.95% |
| Eye irritation | - | 0.8971 | 89.71% |
| Skin irritation | - | 0.8121 | 81.21% |
| Skin corrosion | - | 0.9385 | 93.85% |
| Ames mutagenesis | - | 0.6500 | 65.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6794 | 67.94% |
| Micronuclear | + | 0.6700 | 67.00% |
| Hepatotoxicity | - | 0.5500 | 55.00% |
| skin sensitisation | - | 0.9038 | 90.38% |
| Respiratory toxicity | + | 0.7444 | 74.44% |
| Reproductive toxicity | + | 0.7929 | 79.29% |
| Mitochondrial toxicity | + | 0.7250 | 72.50% |
| Nephrotoxicity | - | 0.5983 | 59.83% |
| Acute Oral Toxicity (c) | III | 0.7296 | 72.96% |
| Estrogen receptor binding | + | 0.7390 | 73.90% |
| Androgen receptor binding | + | 0.7790 | 77.90% |
| Thyroid receptor binding | + | 0.5751 | 57.51% |
| Glucocorticoid receptor binding | + | 0.6226 | 62.26% |
| Aromatase binding | + | 0.6611 | 66.11% |
| PPAR gamma | + | 0.7119 | 71.19% |
| Honey bee toxicity | - | 0.8494 | 84.94% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6000 | 60.00% |
| Fish aquatic toxicity | + | 0.8224 | 82.24% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.94% | 98.95% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.20% | 97.23% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 99.11% | 97.21% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 98.59% | 90.20% |
| CHEMBL236 | P41143 | Delta opioid receptor | 98.36% | 99.35% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.33% | 91.11% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 97.45% | 100.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.35% | 96.09% |
| CHEMBL3837 | P07711 | Cathepsin L | 97.12% | 96.61% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 96.82% | 98.94% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 96.34% | 100.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.17% | 99.17% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.11% | 94.45% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 95.40% | 93.56% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.34% | 93.10% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 94.94% | 98.05% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 94.24% | 98.89% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 93.80% | 96.67% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 93.43% | 85.00% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 93.10% | 92.29% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 92.30% | 96.95% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 92.10% | 89.33% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.99% | 90.71% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 90.95% | 90.17% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 90.12% | 95.50% |
| CHEMBL2535 | P11166 | Glucose transporter | 89.23% | 98.75% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.80% | 93.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 88.47% | 95.89% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 88.10% | 94.00% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 87.84% | 96.00% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 87.45% | 100.00% |
| CHEMBL2163183 | Q9NXA8 | NAD-dependent protein deacylase sirtuin-5, mitochondrial | 87.25% | 96.53% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 86.87% | 82.86% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 86.61% | 95.52% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 86.42% | 98.33% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 86.14% | 93.18% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 85.65% | 89.50% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 84.40% | 98.33% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 84.32% | 96.67% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 83.66% | 96.28% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.47% | 96.90% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 83.44% | 85.11% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 83.32% | 95.56% |
| CHEMBL3891 | P07384 | Calpain 1 | 83.26% | 93.04% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 82.88% | 100.00% |
| CHEMBL301 | P24941 | Cyclin-dependent kinase 2 | 82.58% | 91.23% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 81.75% | 91.71% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 81.59% | 99.15% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 81.07% | 83.14% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 80.85% | 83.10% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 80.52% | 97.14% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 80.36% | 96.37% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139586357 |
| LOTUS | LTS0268953 |
| wikiData | Q77504884 |